about
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathyThe E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy.CARbon DIoxide for the treatment of Febrile seizures: rationale, feasibility, and design of the CARDIF-study.Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial.Whole-body vibration to prevent intensive care unit-acquired weakness: safety, feasibility, and metabolic response.Measuring Energy Expenditure in extracorporeal lung support Patients (MEEP) - Protocol, feasibility and pilot trial.Severe perioperative hyperglycemia attenuates postoperative monocytic function, basophil count and T cell activation.Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.Critical illness myopathy and GLUT4: significance of insulin and muscle contraction.Glycemic variability as a risk factor of intensive care unit-acquired weakness.Secreted Frizzled-Related Protein 2 and Inflammation-Induced Skeletal Muscle Atrophy.Reply: To PMID 24415656.Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy.Accuracy of a subcutaneous continuous glucose management system in critically ill patients.Relation of Resting Membrane Polarization and Insulin Resistance in Critically Ill Patients.Critically Ill Patients With Icu-Acquired Weakness Show Reduced Density of Myosin in Electron Microscope Early After Onset of Critical Illness.Randomised controlled trial using daily electrical muscle stimulation (EMS) in critically ill patients to prevent intensive care unit (icu) acquired weakness (ICUAW).Wie können postoperative Komplikationen bei Patienten mit Frailty vermieden werden?Kasuistik: Late-onset Small-Fiber-Neuropathie nach kritischer ErkrankungDifferential contractile response of critically ill patients to neuromuscular electrical stimulationMuscle wasting and function after muscle activation and early protocol-based physiotherapy: an explorative trialAssociation between potassium concentrations, variability and supplementation, and in-hospital mortality in ICU patients: a retrospective analysis
P50
Q27314918-E997F6EC-9BB8-474E-A2A2-54542118B81EQ34507052-70381B2F-EDFA-4DB3-B638-B3823DDF2F8EQ36980537-70FC26F0-16D1-4BB5-AD06-98ED3BB14AD7Q37112346-9584CEBC-DE49-46CF-8425-50DB09AAA9C4Q37572090-F9726D26-EFA3-453D-84DA-68B94253E70DQ38988350-1DA1B5E2-A297-4ABF-9807-64C3FEB45089Q40309820-6FBDE675-7FE7-4E52-9FF0-D17CF3DB1345Q42643598-8F04016E-9F1C-4A8E-BE88-8A3420A681C9Q43483723-6154C457-133F-4D36-835A-CD5471A6D62DQ46446977-8F0EDC3F-3AB1-48B5-B75A-FF74A7A5C8EDQ51470568-7DD6256D-6A43-495B-B632-78127A740EFBQ52871187-3E03647E-91C5-47E7-9566-09BBA8F496E2Q52880306-38A4D04A-49B4-4DF6-8627-570629B14581Q54351162-DC0B0FA5-9E63-4E02-87AC-DB908A4F6930Q54850186-44DA7ED3-73D7-4AC4-A971-7CCE1C7DB689Q54908211-11AAA092-00E9-4B12-BDD4-EBE85C172F91Q55073179-C7B7782E-02D5-4D1E-9AD6-5FFE8729B9C8Q56963920-64EB0F43-C421-4FAD-9C62-B1698237FFECQ56992457-4C7D70A2-3A90-42F7-A0FE-47A7B5FD41F9Q90042653-7F5D47E8-6C52-467E-BC98-E70874FBC7B8Q90262772-A7520AA0-57AC-4FB7-B622-5202FECC740DQ93119751-30722C5F-EF53-41EA-ABC5-E229136F4C03
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Tobias Wollersheim
@ast
Tobias Wollersheim
@en
Tobias Wollersheim
@es
Tobias Wollersheim
@nl
type
label
Tobias Wollersheim
@ast
Tobias Wollersheim
@en
Tobias Wollersheim
@es
Tobias Wollersheim
@nl
prefLabel
Tobias Wollersheim
@ast
Tobias Wollersheim
@en
Tobias Wollersheim
@es
Tobias Wollersheim
@nl
P214
P106
P1153
8656538900
P21
P214
P31
P496
0000-0002-3170-0996
P734
P735
P7859
viaf-314886622